BRIEF-GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan

LONDON, April 22 Mon Apr 22, 2013 5:07am EDT

LONDON, April 22 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for Anoro Ellipta

(UMEC/Vi) in Japan * Intends to commence global regulatory submissions for UMEC monotherapy later

this year

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.